- 701. chlorophenoxyacetate
- [ ] (UMLS (CSP) C0596330) =Organic Chemical =phenylacetate;
=2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester | - 751. cholera
- [acute diarrheal disease endemic in India and southeast Asia whose causative agent is Vibrio cholerae; can lead to severe dehydration in a matter of hours unless quickly treated. ( CSP )] (UMLS (CSP) C0008354) =Disease or Syndrome ;
=Vibrio Infections;
Gastrointestinal Infection |
- 702. Chlorophycota
- [green algae; in this division of algae, the green pigment of chlorophyll is not masked by other pigments; there are over 7000 species; most live in freshwater, about ten percent are marine. ( CSP )] (UMLS (CSP) C0002032) =Alga
| - 752. cholera
- [vaccines or candidate vaccines used to prevent infection with Vibrio cholerae. ( CSP )] (UMLS (HL7) C0008359) =Pharmacologic Substance; Immunologic Factor =bacterial vaccine;
Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType;
|
- 703. chlorophyll
- [magnesium chlorin pigment related to porphyrin that acts to convert light energy in photosynthetic organisms; gives plants their green color. ( CSP )] (UMLS (CSP) C0008260) =Organic Chemical; Biologically Active Substance ;
=metalloporphyrin;
porphyrin;
Inactive Ingredient Preparations;
=Chlorophyllides;
CHLOROPHYLL 0.5 %;
| - 753. CHOLERA CONTACT
- [ ] (UMLS (ICD9CM) C0260340) =Finding
|
- 704. chloroplast
- [large cellular organelle that contains chlorophyll, consists of a complex lammelar system of membranes, and functions as the site of photosynthesis in green algae and green plant cells. ( CSP )] (UMLS (CSP) C0008266) =Cell Component =organelle;
| - 754. CHOLERA D/T VIB EL TOR
- [ ] (UMLS (ICD9CM) C0343372) =Disease or Syndrome
|
- 705. chloroplast ATPase
- [Proton-translocating ATPases which produce ADENOSINE TRIPHOSPHATE in plants. They derive energy from light-driven reactions that develop high concentrations of protons within the membranous cisternae (THYLAKOIDS) of the CHLOROPLASTS. ( MSH )] (UMLS (CSP) C0162381) =Amino Acid, Peptide, or Protein; Enzyme
| - 755. Cholera Immunization
- (UMLS (HL7) C1548834) =Health Care Activity =Consent Type;
|
- 706. chloroquine
- [antiamebic and antimalarial; chloroquine phosphate is also listed by USP as a suppressant of lupus erythematosus. ( CSP )] (UMLS (CSP) C0008269) =Organic Chemical; Pharmacologic Substance ;
=Aminoquinolines;
Antimalarials;
1 benzazine;
=HYDROXYCHLOROQUINE;
1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, Phosphate (1:2);
Chloroquine Hydrochloride | - 756. cholera toxin
- [enterotoxin from Vibrio cholerae that consists of two major protomers, the heavy (h) or a subunit and the b protomer which consists of 5 light (l) or b subunits. ( CSP )] (UMLS (CSP) C0008356) =Amino Acid, Peptide, or Protein; Enzyme; Hazardous or Poisonous Substance ;
=Enterotoxin;
|
- 707. Chloroquine Hydrochloride
- [The hydrochloride salt of chloroquine, a synthetic quinoline with antimalarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum. Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Chloroquine may also interfere with the biosynthesis of nucleic acids. ( NCI )] (UMLS (NCI) C1383389) CHLOROQUINE HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =chloroquine;
1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, Phosphate (1:2) =CHLOROQUINE HYDROCHLORIDE 50 MG/ML;
| - 757. CHOLERA VACCINATION
- (UMLS (ICD9CM) C0042199) =Therapeutic or Preventive Procedure ;
|
- 708. chlorosis
- [ ] (UMLS (CSP) C0008272) =Disease or Syndrome
| - 758. choleretic
- [gastrointestinal agent that stimulates the flow of bile into the duodenum or stimulates the production of bile by the liver. ( CSP )] (UMLS (CSP) C0008362) =Pharmacologic Substance ;
=Drug;
|
- 709. chlorothiazide
- [thiazide diuretic used to treat hypertension. ( CSP )] (UMLS (CSP) C0008273) =Organic Chemical; Pharmacologic Substance ;
=antihypertensive agent;
benzothiadiazine;
[CV701] THIAZIDES/RELATED DIURETICS;
thiazide =6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide;
Chlorothiazide Sodium;
CHLOROTHIAZIDE 250 MG;
CHLOROTHIAZIDE 250 MG/5ML;
CHLOROTHIAZIDE 500 MG | - 759. cholestane compound
- [C27 hydrocarbon parent structure for the synthesis of mammalian steroids. ( CSP )] (UMLS (CSP) C0008366) =Steroid ;
=Steroid;
sterol =(-)-Cholesterol;
ergosterol;
lanosterol;
sitosterol;
[VT500] VITAMIN D;
Cholestenes;
sterol |
- 710. Chlorothiazide Sodium
- (UMLS (NCI) C0304489) =Organic Chemical; Pharmacologic Substance =chlorothiazide;
=CHLOROTHIAZIDE SODIUM 500 MG | - 760. cholestanol
- [A cholesterol derivative found in human feces, gallstones, eggs, and other biological matter. ( MSH )] (UMLS (CSP) C0012282) =Steroid; Biologically Active Substance
|
- 711. CHLOROTRIANISENE
- [A powerful synthetic, non-steroidal estrogen. ( MSH )] (UMLS (NCI) C0008275) =Organic Chemical; Pharmacologic Substance; Hormone =[HS300] ESTROGENS;
stilbene | - 761. Cholestatic Jaundice
- [JAUNDICE, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired BILE flow in the BILIARY TRACT, such as INTRAHEPATIC CHOLESTASIS, or EXTRAHEPATIC CHOLESTASIS. ( MSH )] (UMLS (NCI) C0022354) =Disease or Syndrome ;
|
- 712. chlorphenamine
- [histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, asthma and in veterinary applications; one of the most widely used of the classical antihistamines. ( CSP )] (UMLS (CSP) C0008281) =Organic Chemical; Pharmacologic Substance ;
=[AH000] ANTIHISTAMINES;
PHENIRAMINE;
pyridine;
[AH400] ANTIHISTAMINES, ALKYLAMINE =DEXCHLORPHENIRAMINE;
CHLORPHENIRAMINE MALEATE;
CHLORPHENIRAMINE POLISTIREX;
CHLORPHENIRAMINE TANNATE;
CHLORPHENIRAMINE MALEATE;
CHLORPHENIRAMINE POLISTIREX;
CHLORPHENIRAMINE TANNATE;
Chlorpheniramine 0.4 MG/ML;
CHLORPHENIRAMINE 4 MG;
CHLORPHENIRAMINE 1 MG;
CHLORPHENIRAMINE 5 MG | - 762. cholesteatoma
- [non-neoplastic keratinizing mass with stratified squamous epithelium, frequently occurring in the meninges, central nervous system, bones of the skull, and most commonly in the middle ear and mastoid region. ( CSP )] (UMLS (CSP) C0008373) =Disease or Syndrome ;
=keratosis;
Middle Ear Disorder =CHOLESTEATOMA MIDDLE EAR |
- 713. Chlorphenesin Carbamate
- (UMLS (NCI) C0055467) =Organic Chemical; Pharmacologic Substance =CHLORPHENESIN;
| - 763. CHOLESTEATOMA EXTERN EAR
- [ ] (UMLS (ICD9CM) C0155398) =Disease or Syndrome
|
- 714. CHLORPHENTERMINE
- [A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of DEXTROAMPHETAMINE. It has been implicated in lipid storage disorders and pulmonary hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1223) ( MSH )] (UMLS (NCI) C0008283) =Organic Chemical; Pharmacologic Substance ;
| - 764. CHOLESTEATOMA MIDDLE EAR
- [A mass of KERATIN-producing squamous EPITHELIUM that resembles an inverted (suck-in) bag of skin in the MIDDLE EAR. It arises from the eardrum (TYMPANIC MEMBRANE) and grows into the MIDDLE EAR causing erosion of EAR OSSICLES and MASTOID that contains the INNER EAR. ( MSH )] (UMLS (ICD9CM) C0155490) =Disease or Syndrome ;
=cholesteatoma;
DISORDER OF EAR NOS |
- 715. CHLORPHENTERMINE HYDROCHLORIDE
- (UMLS (NCI) C0600181) =Organic Chemical; Pharmacologic Substance ;
| - 765. CHOLESTEATOMA OF ATTIC
- (UMLS (ICD9CM) C0155489) =Disease or Syndrome ;
|
- 716. CHLORPROTHIXENE
- [A thioxanthine with effects similar to the phenothiazine antipsychotics. ( MSH )] (UMLS (NCI) C0008290) =Organic Chemical; Pharmacologic Substance ;
=Thioxanthenes;
[CN701] PHENOTHIAZINES/RELATED, ANTIPSYCHOTICS | - 766. Cholesteatoma of middle ear and mastoid
- (UMLS (ICD9CM) C0008374) =Disease or Syndrome ;
|
- 717. chlortetracycline
- [A TETRACYCLINE with a 7-chloro substitution. ( MSH )] (UMLS (CSP) C0008293) =Organic Chemical; Antibiotic ;
=[OP201] ANTIBACTERIALS, TOPICAL OPHTHALMIC;
TO BE DELETED INGREDIENT PREPARATIONS;
[AM250] TETRACYCLINES;
=2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride(4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))- | - 767. CHOLESTERIN GRANULOMA
- (UMLS (ICD9CM) C0155492) =Disease or Syndrome ;
|
- 718. chlorzoxazone
- [A synthetic chlorobenzoxazolinone derivative, mild sedative, and centrally acting muscle relaxant in acute painful musculoskeletal diseases, Chlorzoxazone acts at the spinal cord and subcortical levels of the brain to inhibit multisynaptic reflex arcs that maintain muscle spasms. (NCI04) ( NCI )] (UMLS (CSP) C0008296) =Organic Chemical; Pharmacologic Substance ;
=Benzoxazoles;
[MS200] SKELETAL MUSCLE RELAXANTS =CHLORZOXAZONE 250 MG;
CHLORZOXAZONE 500 MG;
| - 768. Cholesterol 20-22 Desmolase
- [Encoded by human CYP11A1 Gene (Cytochrome P450 Family), 521-aa 60-kDa (precursor) Cytochrome P450C11A1 is a mitochondrial inner membrane P450 heme-thiolate monooxygenase that catalyzes a side-chain cleavage reaction conversion of cholesterol to pregnenolone, the first (rate-limiting) step in the synthesis of steroid hormones. CYP11A1 defects cause congenital adrenal insufficiency (CAI) and congenital lipoid adrenal hyperplasia (CLAH). P450 enzymes catalyze reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. (NCI) ( NCI )] (UMLS (NCI) C0008381) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 719. CHNG HND MUS/TEN LNG NEC
- [ ] (UMLS (ICD9CM) C0177596) =Therapeutic or Preventive Procedure
| - 769. Cholesterol 7 Alpha-Monooxygenase
- [Encoded by human CYP7A1 Gene (Cytochrome P450 Family), 504-aa 58-kDa Cytochrome P450 7A1 is an endoplasmic reticulum membrane-bound P450 heme-thiolate monooxygenase in the liver that catalyzes the first (rate-limiting) reaction in the cholesterol catabolic pathway: cholesterol conversion to bile acids, the major site of regulation of bile acid synthesis and the primary mechanism for removal of cholesterol from the body. P450 enzymes catalyze reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. (NCI) ( NCI )] (UMLS (NCI) C0008396) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 720. CHOANAL ATRESIA
- [Congenital bony or membranous occlusion of one or both choanae, due to failure of the embryonic bucconasal membrane to rupture. ( MSH )] (UMLS (ICD9CM) C0008297) =Congenital Abnormality =nasal disorder;
Aangeboren afwijkingen luchtwegen | - 770. cholesterol analog
- [synthetic or natural chemical compounds which resemble cholesterols in structure and/or function. ( CSP )] (UMLS (CSP) C0596331) =Steroid ;
=steroid analog;
|
- 721. Choanichthyes
- [ ] (UMLS (CSP) C0599048) =Fish
| - 771. cholesterol biosynthesis
- [The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. [GOC:ai] ( GO )] (UMLS (CSP) C0599474) =Molecular Function
|
- 722. Choctaw
- (UMLS (HL7) C0574569) =Language =WesternMuskogean;
◊ (UMLS (HL7) C0682100) Population Group American Indian; Clifton Choctaw; Jena Choctaw; Mississippi Choctaw; Mowa Band of Choctaw; Oklahoma Choctaw | - 772. cholesterol ester
- [fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in human plasma; accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. ( CSP )] (UMLS (CSP) C0008387) =Steroid; Biologically Active Substance ;
=sterol ester;
|
- 723. Choctaw Nation of Oklahoma
- (UMLS (HL7) C1554265) =Population Group =NativeEntityContiguous;
| - 773. cholesterol ester storage disease
- [rare benign adult form of inherited lysosomal lipid storage disease that is due to deficiency of acid lipase; results in an accumulation of neutral lipids, particularly cholesterol esters, within cells (particularly leukocytes, fibroblasts, and liver cells); it is an allelic variant of Wolman disease. ( CSP )] (UMLS (CSP) C0008384) =Disease or Syndrome =inborn lipid storage disorder;
inborn lysosomal enzyme disorder |
- 724. CHOD
- (UMLS (NCI) C0082139) =Therapeutic or Preventive Procedure
| - 774. cholesterol esterase
- [acts on esters of sterols and long chain fatty acids may bring about esterification of sterols activated by bile salts. ( CSP )] (UMLS (CSP) C0008385) =Amino Acid, Peptide, or Protein; Enzyme ;
=carboxylesterase;
|
- 725. choice
- [act of making a selection among two or more alternatives, usually after a period of deliberation. ( CSP )] (UMLS (CSP) C0008300) =Individual Behavior =decision making;
| - 775. Cholesterol Granuloma
- (UMLS (NCI) C0333411) =Pathologic Function
|
- 726. Choking
- [A condition caused by blocking the airways to the lungs and interference with the respiration by compression or obstruction of the larynx or trachea. ( NCI )] (UMLS (NCI) C0008301) =Finding
| - 776. Cholesterol Homeostasis
- [Any of the processes involved in the maintenance of an internal equilibrium of cholesterol within an organism or cell. (Gene Ontology) ( NCI )] (UMLS (NCI) C1326960) =Physiologic Function
|
- 727. CHOL
- [A measurement of the cholesterol in a biological specimen. ( NCI )] (UMLS (NCI) C1445957) Cholesterol;
Serum Total Cholesterol Measurement =Laboratory Procedure ;
| - 777. cholesterol oxide
- [ ] (UMLS (CSP) C0596332) =Steroid ;
=(-)-Cholesterol;
|
- 728. cholagogue
- [ ] (UMLS (CSP) C0008303) =Pharmacologic Substance
| - 778. Cholesterol Screening
- (UMLS (HL7) C1548835) =Health Care Activity =Consent Type;
|
- 729. cholanate compound
- [steroid bile acids and salts; primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine, secondary bile acids are further modified by bacteria in the intestine; cholanate compounds play an important role in the digestion and absorption of fat. ( CSP )] (UMLS (CSP) C0178549) =Steroid; Biologically Active Substance =Steroid;
=chenodeoxycholate;
cholate;
ursodeoxycholate;
| - 779. Cholesterolosis of gallbladder
- [ ] (UMLS (ICD9CM) C0152456) =Disease or Syndrome
|
- 730. Cholangiocarcinoma
- [(ko-LAN-jee-o-sar-KO-ma) A tumor of the connective tissues of the bile ducts. ( NCI )] (UMLS (NCI) C0206698) =Neoplastic Process =adenocarcinoma;
| - 780. cholestyramine
- [strongly basic anion exchange resin used to extract bile salts and cholesterol, to treat diarrhea and biliary obstruction, and as an antipruritic. ( CSP )] (UMLS (CSP) C0008402) =Organic Chemical; Pharmacologic Substance ;
=antihypercholesterolemic agent;
[CV350] ANTILIPEMIC AGENTS;
polystyrene;
quaternary ammonium compound =CHOLESTYRAMINE 4 GM;
CHOLESTYRAMINE 4 GM/5GM;
CHOLESTYRAMINE 4 GM/9GM |
- 731. CHOLANGIOGRAM NEC
- [ ] (UMLS (ICD9CM) C0029538) =Diagnostic Procedure ;
| - 781. choline
- [essential nutrient that is part of the B-complex family of vitamins and is a constituent of lecithin; it is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism; it also aids in hormone production and is needed for the proper transmission of nerve impulses, liver function and gallbladder regulation. ( CSP )] (UMLS (CSP) C0008405) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =ammonium compound;
Betaine;
Ethanolamines;
[TN900] THERAPEUTIC NUTRIENTS/MINERALS/ELECTROLYTES, OTHER =acetylcholine;
2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium Chloride;
METHACHOLINE;
2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium Chloride;
CHOLINE (AS BITARTRATE);
CHOLINE CHLORIDE;
SUCCINYLCHOLINE;
choline salicylate;
Choline, hydroxide, compound with Theophylline(1:1);
CHOLINE (AS BITARTRATE);
CHOLINE CHLORIDE;
Lecithin 420 MG Oral Capsule;
MAGNACAL NUTRITIONAL SUPPLEMENT LIQUID;
NURSOY LIQUID;
S-M-A IRON FORTIFIED,INFANT FORMULA CONC,ORAL;
S-M-A IRON FORTIFIED,INFANT FORMULA LIQUID;
S-M-A LO-IRON,INFANT FORMULA CONC,ORAL;
S-M-A LO-IRON,INFANT FORMULA LIQUID;
S-M-A LO-IRON,INFANT FORMULA PWDR;
S-M-A IRON FORTIFIED,INFANT FORMULA PWDR;
CHOLINE 25 MG;
CHOLINE 300 MG;
CHOLINE 500 MG;
TRAUM-AID HBC PWDR (LEMONCREME);
CHOLINE 100 MG;
CHOLINE 100 MG/240ML;
CHOLINE 100 MG/30ML;
CHOLINE 102 MG/240ML;
CHOLINE 107 MG;
CHOLINE 107 MG/240ML;
CHOLINE 111 MG;
CHOLINE 114 MG/240ML;
CHOLINE 118 MG/240ML;
CHOLINE 125 MG/240ML;
CHOLINE 150 MG/240ML;
CHOLINE 16.7 MG/5ML;
CHOLINE 452 MG/L;
CHOLINE 454 MCG/ML;
CHOLINE 520 MG/L;
CHOLINE 530 MG/L;
CHOLINE 71 MG/240ML;
CHOLINE 75 MG;
CHOLINE 75 MG/240ML |
- 732. cholangiography
- [radiographic examination of the bile ducts after injection with a contrast medium. ( CSP )] (UMLS (CSP) C0008307) =Diagnostic Procedure =biliary tract imaging/visualization;
| - 782. choline acetylase
- [An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6. ( MSH )] (UMLS (CSP) C0008407) =Amino Acid, Peptide, or Protein; Enzyme ;
=Acetyltransferase;
|
- 733. cholangiole
- [ ] (UMLS (CSP) C0227516) =Body Part, Organ, or Organ Component
| - 783. choline analog
- [ ] (UMLS (CSP) C0597837) =Organic Chemical; Biologically Active Substance ;
|
- 734. cholangitis
- [Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both. ( MSH )] (UMLS (CSP) C0008311) =Disease or Syndrome =Bile Duct Diseases;
=Cholangitis, Sclerosing | - 784. choline deficiency
- [state in which choline is absent or in diminished amount relative to the normal requirement of an organism or a biologic system. ( CSP )] (UMLS (CSP) C0008412) =Disease or Syndrome =Deficiency of B-complex components;
|
- 735. cholate
- [major primary bile acid, its salts and esters; produced in the liver and usually conjugated with glycine or taurine; facilitates fat absorption and cholesterol excretion. ( CSP )] (UMLS (CSP) C0109497) =Steroid; Pharmacologic Substance; Biologically Active Substance =cholanate compound;
=choleate | - 785. choline esterase II
- [enzyme of the hydrolase class that catalyzes the cleavage of the acyl group from various esters of choline, including acetylcholine, and some related compounds the enzyme occurs primarily in the serum, liver, and pancreas determination of enzyme activity is used to test liver function, succinylcholine sensitivity, and whether organophosphate insecticide poisoning has occurred. ( CSP )] (UMLS (CSP) C0008429) =Amino Acid, Peptide, or Protein; Enzyme ;
=Ester Hydrolase;
carboxylesterase =Succinylcholinesterase |
- 736. choleate
- [bile acid formed by bacterial action from cholate; usually conjugated with glycine or taurine; deoxycholate acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. ( CSP )] (UMLS (CSP) C0086123) =Steroid; Pharmacologic Substance; Biologically Active Substance =cholate;
| - 786. choline inhibitor
- [any substance or agent which suppresses, prevents or opposes the action of choline. ( CSP )] (UMLS (CSP) C0596333) =Pharmacologic Substance ;
=inhibitor/antagonist;
|
- 737. cholecystectomy
- [surgical removal of the gallbladder. ( CSP )] (UMLS (CSP) C0008320) =Therapeutic or Preventive Procedure ;
=biliary tract surgery;
| - 787. choline phosphatase
- [ ] (UMLS (CSP) C0070943) =Amino Acid, Peptide, or Protein; Enzyme
|
- 738. cholecystitis
- [inflammation of the gallbladder; generally caused by impairment of bile flow, gallstones in the biliary tract, infections, or other diseases. ( CSP )] (UMLS (CSP) C0008325) =Disease or Syndrome ;
=Unspecified disorder of gallbladder;
| - 788. Choline, hydroxide, compound with Theophylline(1:1)
- [The choline salt of theophylline with an anti-asthmatic property. Oxtriphylline appears to inhibit phosphodiesterase and prostaglandin production, regulates calcium flux and intracellular calcium distribution, and antagonizes adenosine. Physiologically, this agent causes relaxation of bronchial smooth muscle, produces vasodilation (except in cerebral vessels), stimulates cardiac muscle, as well as induces diuresis and gastric acid secretion. It may also suppress inflammation and improve contractility of the diaphragm. ( NCI )] (UMLS (NCI) C0055578) =Organic Chemical; Pharmacologic Substance =choline;
3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione;
[RE104] BRONCHODILATORS, XANTHINE-DERIVATIVE;
=cholinophyllin 10 MG/ML;
cholinophyllin 20 MG/ML;
cholinophyllin 200 MG;
cholinophyllin 400 MG;
cholinophyllin 600 MG;
OXTRIPHYLLINE 100 MG;
|
- 739. Cholecystitis/cholelithiasis
- (UMLS (ICPC) C0267853) (Cholecystitis/cholelithiasis; KOLEZISTITISA/KOLELITIASISA; Galdesten/galdeblaerebetaendelse; Cholecystitis/cholelithiasis; SAPPIRAKON TULEHDUS/ SAPPIKIVET; Cholecystite/cholelithiase; Cholezystitis/Cholelithiasis; xoletzistitis o avanim; cholecystitis/cholelithiasis; Colecistite/colelitiasi; GALLESTEN/GALLEVEISBETENNELSE - k80 - k81 - k82 - k83 - k87; Colecistite/colelitiase; Colecistitis/colelitiasis; INFLAMMATION I GALLBLASA/GALLSTEN) =Disease or Syndrome =Body System, Gastrointestinal; Diagnosis/Diseases Component
| - 789. cholinergic
- [ ] (UMLS (CSP) C0599668) =Functional Concept
|
- 740. cholecystolithiasis
- [Presence or formation of GALLSTONES in the GALLBLADDER. ( MSH )] (UMLS (CSP) C0947622) Gallbladder Calculus;
Gallbladder Stone =Disease or Syndrome | - 790. cholinergic agent
- [drug used for its actions in stimulating cholinergic systems. ( CSP )] (UMLS (CSP) C0242893) =Pharmacologic Substance ;
=neuropharmacologic agent;
=acetylcholine;
arecoline;
2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium Chloride;
muscarine;
neostigmine;
(-)-Nicotine;
PHYSOSTIGMINE;
PILOCARPINE;
PYRIDOSTIGMINE;
METHACHOLINE;
|
- 741. CHOLECYSTOSTOMY NEC
- [ ] (UMLS (ICD9CM) C0029540) =Therapeutic or Preventive Procedure ;
| - 791. Cholinergic Agonist
- [A class of agents that interact with cholinergic receptors, i.e., nicotinic and muscarinic receptors. ( NCI )] (UMLS (NCI) C0242894) =Pharmacologic Substance ;
|
- 742. Cholecystotomy and cholecystostomy
- [ ] (UMLS (ICD9CM) C0176891) =Therapeutic or Preventive Procedure
| - 792. cholinergic blocking agent
- [Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. ( MSH )] (UMLS (CSP) C0242897) =Pharmacologic Substance ;
|
- 743. CHOLECYSTOTOMY NEC
- [ ] (UMLS (ICD9CM) C0176894) =Therapeutic or Preventive Procedure
| - 793. Cholinergic Differentiation Factor
- [Leukemia Inhibitory Factor (LIF) affects many systems, including hematopoietic, embryonic, bone, hepatic, neuronal, and fat tissues. LIF induces MHC class I HLA-G expression by cytotrophoblasts, which is essential in implantation and may facilitate immune tolerance of the conceptus at the maternal-fetal interface. LIF, secreted by ureteric bud cells, converts kidney mesenchyme to epithelia, which then forms nephrons. LIF and BMP2 cytokines signal through different receptors and transcription factors (STATs and SMADs) and act in synergy on neural progenitors to induce astrocytes. Transcriptional co-activator p300 interacts with STAT3 in a cytokine-independent manner and with SMAD1 in a cytokine-dependent manner. Formation of a STAT3/SMAD1 complex, bridged by p300, mediates cooperative signaling of LIF and BMP2 and induction of astrocytes from neuronal progenitors. (from OMIM and NCI) ( NCI )] (UMLS (NCI) C1453955) D Factor;
D-Factor;
Differentiation Stimulating Factor;
Differentiation-Stimulating Factor;
Human Interleukin in DA Cells;
Leukemia Inhibitory Factor;
Leukemia-Inhibitory Factor;
LIF;
Melanoma-Derived LPL Inhibitor;
MLPLI =Amino Acid, Peptide, or Protein; Immunologic Factor |
- 744. Choledochal Cyst
- [A congenital anatomic malformation of a bile duct, including cystic dilatation of the extrahepatic bile duct or the large intrahepatic bile duct. Classification is based on the site and type of dilatation. Type I is most common. ( MSH )] (UMLS (NCI) C0008340) =Congenital Abnormality; Disease or Syndrome =Common Bile Duct Diseases;
cyst | - 794. cholinergic nerve differentiation factor
- [ ] (UMLS (CSP) C0598770) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 745. CHOLEDOCHOENTEROSTOMY
- [ ] (UMLS (ICD9CM) C0193558) =Therapeutic or Preventive Procedure
| - 795. cholinergic neuronal differentiation factor
- [ ] (UMLS (CSP) C0068611) =Amino Acid, Peptide, or Protein; Hormone
|
- 746. CHOLEDOCHOHEPAT INTUBAT
- (UMLS (ICD9CM) C0193491) =Therapeutic or Preventive Procedure
| - 796. cholinergic receptor
- [since the 2 subtypes are distinctly different receptors, use MUSCARINIC or NICOTINIC whenever possible; use this general term only for unspecified binding of acetylcholine and related ligands. ( CSP )] (UMLS (CSP) C0034792) =Amino Acid, Peptide, or Protein; Receptor ;
=neurotransmitter receptor;
=muscarinic receptor;
nicotinic receptor;
|
- 747. choledocholithiasis
- [Presence or formation of GALLSTONES in the COMMON BILE DUCT. ( MSH )] (UMLS (CSP) C0701818) =Disease or Syndrome
| - 797. Cholinergic Receptor, Muscarinic 1
- [The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The muscarinic cholinergic receptor 1 is involved in mediation of vagally-induced bronchoconstriction and in the acid secretion of the gastrointestinal tract. The gene encoding this receptor is localized to 11q13, with MDU1 proximally and COX8 distally located. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C1318050) CHRM1;
Muscarinic Acetylcholine Receptor M1 =Amino Acid, Peptide, or Protein; Receptor |
- 748. CHOLEDOCHOPLASTY
- [ ] (UMLS (ICD9CM) C0702152) =Therapeutic or Preventive Procedure ;
| - 798. Cholinergic Receptor, Muscarinic 1 Gene
- [This gene is involved in G protein-coupled receptor signal transduction that is elicited by acetylcholine interactions. ( NCI )] (UMLS (NCI) C1332758) CHRM1;
CHRM1 Gene =Gene or Genome ;
|
- 749. cholelith
- [presence or formation of gallstones in the gallbladder. ( CSP )] (UMLS (CSP) C0008350) =Disease or Syndrome ;
=Unspecified disorder of gallbladder;
=Common Bile Duct Calculi | - 799. Cholinergic Receptor, Muscarinic 3
- [The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The muscarinic cholinergic receptor 3 controls smooth muscle contraction and its stimulation causes secretion of glandular tissue. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C1334832) CHRM3;
Muscarinic Acetylcholine Receptor M3 =Amino Acid, Peptide, or Protein; Receptor |
- 750. CHOLEPERITONITIS
- [ ] (UMLS (ICD9CM) C1561635) =Disease or Syndrome
| - 800. Cholinergic Receptor, Muscarinic 3 Gene
- [This gene plays a role in the regulation of smooth muscle contraction and glandular tissue secretions. ( NCI )] (UMLS (NCI) C1332759) CHRM3;
CHRM3 Gene =Gene or Genome ;
|
home
